The HIVACAR project seeks to provide a therapeutic alternative to the current treatment of HIV, lifelong combined antiretroviral therapy (cART). By focusing on an innovative strategy based on the patient's immune system, this project aims to achieve a functional cure for HIV. This could revolutionize HIV management on a global scale, offering a more accessible, safe, and affordable treatment for people living with HIV.
🚀 Why HIVACAR?
👥 Collaborative Power
European research network with 14 clinical sites advancing cure research together
🌐 Scalable Future
Solutions designed for broad, global deployment—scientifically backed, clinically sound
💡 Beyond Suppression
Not just reducing viral load—retraining the immune system to control HIV long term
Clinical Trials and Development Phases
The HIVACAR project is currently in phase I/IIa of clinical trials, where new therapeutic strategies are being tested. This process allows for the evaluation of the safety and efficacy of treatments in a rigorous clinical setting. The goal is to establish a safe and accessible treatment for people living with HIV.
🧪 How HIVACAR Works
A triple-action therapeutic strategy:
💉 1. Therapeutic Vaccines
Stimulate robust, patient-tailored immune responses to HIV antigens
⚡ 2. Latency-Reversal Agents (LRA)
Unmask dormant HIV to make it visible to the immune system
🧫 3. Broadly Neutralizing Antibodies (bNAbs)
Target and eliminate active viral particles with precision
📢 Frequently Asked Questions
Here are some common questions about our company.
A therapeutic method that controls HIV without daily medication by boosting natural immune responses.
Not in the traditional sense. It includes therapeutic vaccines, not preventive ones meant for those already living with HIV.
Clinical trials are underway. Subscribe for news on when broader access may begin.
The Objectives of the HIVACAR Project
Title: An Innovative Scientific Project to Combat HIV
The potential side effects of medications.
The risk of developing resistance to current treatments.
Lifelong adherence is necessary to maintain the effectiveness of the treatment.
Partnerships with the Community
Title: Collaboration with People Living with HIV in Europe
The project is supported by the European AIDS Treatment Group (EATG), which represents the voice of people living with HIV in Europe. This ensures that the perspectives and needs of the community are taken into account throughout the project's development, thus ensuring a patient-centered approach.
